<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02776345</url>
  </required_header>
  <id_info>
    <org_study_id>1447</org_study_id>
    <nct_id>NCT02776345</nct_id>
  </id_info>
  <brief_title>Ultrasound Guided Interventions of Calcific Tendonitis of Rotator Cuff (SUCTION)</brief_title>
  <acronym>SUCTION</acronym>
  <official_title>Study to Evaluate Ultrasound Guided Interventions of Calcific Tendonitis of Rotator Cuff- International CollabratioN (SUCTION)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hamilton Health Sciences Corporation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Postgraduate Institute of Medical Education and Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hamilton Health Sciences Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether minimally invasive treatments like
      ultrasound guided needle fragmentation with and without lavage is associated with better
      clinical outcomes compared to the subacromial bursal corticosteroid injection treatment only.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objectives of this study are to compare the clinical outcomes of the three treatment
      arms: ultrasound guided needle fragmentation with lavage, ultrasound guided needle
      fragmentation without lavage, and subacromial bursal corticosteroid injection treatment. The
      study design is a randomized control trial.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2018</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease in Pain as measured by the Visual analog scale from 1-10</measure>
    <time_frame>8 months</time_frame>
    <description>Pain in the original symptomatic area of the rotator cuff will be reassessed using the visual analog scale from 1-10 (1 being the lowest pain and 10 being the highest)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Decreased Range of Motion in the shoulder measured in degrees</measure>
    <time_frame>8 months</time_frame>
    <description>Abduction, internal rotation, external rotation and circumduction of the shoulder</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications and co existing conditions not detected prior to the procedure</measure>
    <time_frame>Post ultrasound guided procedure through completion of study, up to one year</time_frame>
    <description>Infection, procedure induced tendon tears, reduced range of motion ( from other causes such as frozen shoulder), and other adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Costs and health resource utilization as measured by administrative and billing data related to treatment</measure>
    <time_frame>Up to 8-12 months post surgery</time_frame>
    <description>Treatment-related costs to the healthcare system and/or patient through billing codes and data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generic physical and mental health as measured by EuroQol</measure>
    <time_frame>Up to 8-12 months post surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The ultrasound appearance of the targeted calcification</measure>
    <time_frame>Up to 8-12 months post surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Rotator Cuff Calcific Tendonitis</condition>
  <arm_group>
    <arm_group_label>Ultrasound guided Needle Fragmentation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound guided Needle Fragmentation (Intervention):
Using 15-20 to and fro gentle movements of the needle tip, the calcification will be fragmented, with the needle tip within the pseudocapsule. The needle tip will be retracted into the subacromial bursa and 3 ml of 0.5% sensorcaine and 1 ml of steroid ( Depomedrol- 40mg/ml) will be injected into the bursa. The needle will then be removed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>US guided needle fragmentation &amp; Lavage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Using local anesthetic and strict aseptic precautions, the tip of the 18-20 gauge needle will be advanced into the sub acromial bursa under ultrasound guidance and 2ml. of local anesthetic ( 1% xylocaine) will be injected into the bursa. The needle tip will be advanced into the supraspinatus tendon and ½ ml or less of 0.5% Sensorcaine will be injected into the pseudo capsule around the calcification. Using 15-20 to and fro gentle movements of the needle tip, the calcification will be fragmented, with the needle tip within the pseudo capsule. During this procedure, or after the fragmentation, using a syringe of saline or local anesthetic( 1% xylocaine) and with pumping action of the syringe the calcification with be sucked into the syringe.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultrasound guided subacromial injection</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Using local anesthetic and strict aseptic precautions, the tip of the 22 gauge needle will be advanced into the sub acromial bursa under ultrasound guidance and 4 ml. of local anesthetic ( 0.5% xylocaine) and 1 ml of steroid( Depomedrol 40 mg/ml) will be injected into the bursa. The needle will then be removed. Post procedure US images in the short and long axis planes will be obtained and documented. The patient's post procedure pain on a scale of 10 and their range of shoulder movement (abduction) will be assessed and documented.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ultrasound guided Needle Fragmentation</intervention_name>
    <description>Using 15-20 to and fro gentle movements of the needle tip, the calcification will be fragmented, with the needle tip within the pseudocapsule. The needle tip will be retracted into the subacromial bursa and 3 ml of 0.5% sensorcaine and 1 ml of steroid ( Depomedrol- 40mg/ml) will be injected into the bursa. The needle will then be removed.</description>
    <arm_group_label>Ultrasound guided Needle Fragmentation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>US guided needle fragmentation &amp; Lavage</intervention_name>
    <description>Using local anesthetic and strict aseptic precautions, the tip of the 18-20 gauge needle will be advanced into the sub acromial bursa under ultrasound guidance and 2ml. of local anesthetic ( 1% xylocaine) will be injected into the bursa. The needle tip will be advanced into the supraspinatus tendon and ½ ml or less of 0.5% Sensorcaine will be injected into the pseudo capsule around the calcification. Using 15-20 to and fro gentle movements of the needle tip, the calcification will be fragmented, with the needle tip within the pseudo capsule. During this procedure, or after the fragmentation, using a syringe of saline or local anesthetic( 1% xylocaine) and with pumping action of the syringe the calcification with be sucked into the syringe.</description>
    <arm_group_label>US guided needle fragmentation &amp; Lavage</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ultrasound guided subacromial injection</intervention_name>
    <description>Using local anesthetic and strict aseptic precautions, the tip of the 22 gauge needle will be advanced into the sub acromial bursa under ultrasound guidance and 4 ml. of local anesthetic ( 0.5% xylocaine) and 1 ml of steroid( Depomedrol 40 mg/ml) will be injected into the bursa. The needle will then be removed. Post procedure US images in the short and long axis planes will be obtained and documented. The patient's post procedure pain on a scale of 10 and their range of shoulder movement (abduction) will be assessed and documented.</description>
    <arm_group_label>Ultrasound guided subacromial injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adult men or women ages 18 to 60 years

          2. Shoulder pain ( including impingement pain) and reduced range of shoulder movement for
             greater than 6 months with no relief from non-operative means (physiotherapy,
             nonsteroidal anti-inflammatory medication, rest).

          3. Documentation of failed physiotherapy and conservative management.

          4. Calcific tendonitis as diagnosed on ultrasound.

          5. Informed consent from participant.

          6. Ability to speak, understand and read in the language of the clinical site.

        Exclusion Criteria:

          1. Previous inclusion in a study involving calcific tendonitis of the rotator cuff

          2. Evidence of a calcification in any of the rotator cuff tendons except the
             supraspinatus tendon.

          3. Presence of a tear of the rotator cuff.

          4. The supraspinatus tendon calcification is more than 1.5 cm is its largest dimension.

          5. Concomitant clinical or MRI diagnosis of frozen shoulder.

          6. Previous rotator cuff or shoulder surgery.

          7. Those on blood thinners.

          8. Those with allergies to medication used.

          9. Those with a skin infection at the site of needle entry.

         10. Immunosuppressive medication use.

         11. Chronic pain syndromes.

         12. Significant medical co-morbidities (requiring daily assistance).

         13. Ongoing litigation or compensation claims secondary to shoulder problems.

         14. Age below 18 years and above 60 years.

         15. Any other reasons given to exclude the patient.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hema N Choudur, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hamilton Health Sciences Corporation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hang Yu, BHSc.</last_name>
    <phone>6478659385</phone>
    <email>henry.yu@medportal.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michelle L Kuang, BSc.</last_name>
    <phone>2899256990</phone>
    <email>michelle.kuang@medportal.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hamilton General Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L9L2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hema Choudur, MBBS,FRCPC</last_name>
      <phone>905-527-4322</phone>
      <phone_ext>46521</phone_ext>
      <email>choudur@hhsc.ca</email>
    </contact>
    <investigator>
      <last_name>Hema N Choudur, MBBS,FRCPC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Fusaro I, Orsini S, Diani S, Saffioti G, Zaccarelli L, Galletti S. Functional results in calcific tendinitis of the shoulder treated with rehabilitation after ultrasonic-guided approach. Musculoskelet Surg. 2011 Jul;95 Suppl 1:S31-6. doi: 10.1007/s12306-011-0119-6.</citation>
    <PMID>21479869</PMID>
  </reference>
  <reference>
    <citation>Kachewar SG, Kulkarni DS. Calcific tendinitis of the rotator cuff: a review. J Clin Diagn Res. 2013 Jul;7(7):1482-5. doi: 10.7860/JCDR/2013/4473.3180. Epub 2013 Jul 1.</citation>
    <PMID>23998102</PMID>
  </reference>
  <reference>
    <citation>del Cura JL, Torre I, Zabala R, Legórburu A. Sonographically guided percutaneous needle lavage in calcific tendinitis of the shoulder: short- and long-term results. AJR Am J Roentgenol. 2007 Sep;189(3):W128-34.</citation>
    <PMID>17715078</PMID>
  </reference>
  <reference>
    <citation>Yoo JC, Koh KH, Park WH, Park JC, Kim SM, Yoon YC. The outcome of ultrasound-guided needle decompression and steroid injection in calcific tendinitis. J Shoulder Elbow Surg. 2010 Jun;19(4):596-600. doi: 10.1016/j.jse.2009.09.002. Epub 2009 Dec 2.</citation>
    <PMID>19959377</PMID>
  </reference>
  <reference>
    <citation>Aina R, Cardinal E, Bureau NJ, Aubin B, Brassard P. Calcific shoulder tendinitis: treatment with modified US-guided fine-needle technique. Radiology. 2001 Nov;221(2):455-61.</citation>
    <PMID>11687690</PMID>
  </reference>
  <reference>
    <citation>Sconfienza LM, Bandirali M, Serafini G, Lacelli F, Aliprandi A, Di Leo G, Sardanelli F. Rotator cuff calcific tendinitis: does warm saline solution improve the short-term outcome of double-needle US-guided treatment? Radiology. 2012 Feb;262(2):560-6. doi: 10.1148/radiol.11111157. Epub 2011 Dec 5.</citation>
    <PMID>22143923</PMID>
  </reference>
  <reference>
    <citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008 Apr 26;336(7650):924-6. doi: 10.1136/bmj.39489.470347.AD.</citation>
    <PMID>18436948</PMID>
  </reference>
  <reference>
    <citation>Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull. 1968 Oct;70(4):213-20.</citation>
    <PMID>19673146</PMID>
  </reference>
  <reference>
    <citation>Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005 May;37(5):360-3.</citation>
    <PMID>15883903</PMID>
  </reference>
  <reference>
    <citation>Zhu J, Jiang Y, Hu Y, Xing C, Hu B. Evaluating the long-term effect of ultrasound-guided needle puncture without aspiration on calcifying supraspinatus tendinitis. Adv Ther. 2008 Nov;25(11):1229-34. doi: 10.1007/s12325-008-0115-x.</citation>
    <PMID>18998062</PMID>
  </reference>
  <reference>
    <citation>Chiou HJ, Chou YH, Wu JJ, Huang TF, Ma HL, Hsu CC, Chang CY. The role of high-resolution ultrasonography in management of calcific tendonitis of the rotator cuff. Ultrasound Med Biol. 2001 Jun;27(6):735-43.</citation>
    <PMID>11516532</PMID>
  </reference>
  <reference>
    <citation>De Zordo T, Ahmad N, Ødegaard F, Girtler MT, Jaschke W, Klauser AS, Chhem RK, Romagnoli C. US-guided therapy of calcific tendinopathy: clinical and radiological outcome assessment in shoulder and non-shoulder tendons. Ultraschall Med. 2011 Jan;32 Suppl 1:S117-23. doi: 10.1055/s-0029-1245333. Epub 2010 Apr 22.</citation>
    <PMID>20414859</PMID>
  </reference>
  <reference>
    <citation>Farin PU, Räsänen H, Jaroma H, Harju A. Rotator cuff calcifications: treatment with ultrasound-guided percutaneous needle aspiration and lavage. Skeletal Radiol. 1996 Aug;25(6):551-4.</citation>
    <PMID>8865489</PMID>
  </reference>
  <reference>
    <citation>Oliva F, Via AG, Maffulli N. Physiopathology of intratendinous calcific deposition. BMC Med. 2012 Aug 23;10:95. doi: 10.1186/1741-7015-10-95. Review.</citation>
    <PMID>22917025</PMID>
  </reference>
  <reference>
    <citation>Ogon P, Suedkamp NP, Jaeger M, Izadpanah K, Koestler W, Maier D. Prognostic factors in nonoperative therapy for chronic symptomatic calcific tendinitis of the shoulder. Arthritis Rheum. 2009 Oct;60(10):2978-84. doi: 10.1002/art.24845.</citation>
    <PMID>19790063</PMID>
  </reference>
  <reference>
    <citation>Vignesh KN, McDowall A, Simunovic N, Bhandari M, Choudur HN. Efficacy of ultrasound-guided percutaneous needle treatment of calcific tendinitis. AJR Am J Roentgenol. 2015 Jan;204(1):148-52. doi: 10.2214/AJR.13.11935. Review.</citation>
    <PMID>25539250</PMID>
  </reference>
  <results_reference>
    <citation>Speed CA, Hazleman BL. Calcific tendinitis of the shoulder. N Engl J Med. 1999 May 20;340(20):1582-4.</citation>
    <PMID>10332023</PMID>
  </results_reference>
  <results_reference>
    <citation>Serafini G, Sconfienza LM, Lacelli F, Silvestri E, Aliprandi A, Sardanelli F. Rotator cuff calcific tendonitis: short-term and 10-year outcomes after two-needle us-guided percutaneous treatment--nonrandomized controlled trial. Radiology. 2009 Jul;252(1):157-64. doi: 10.1148/radiol.2521081816. Erratum in: Radiology. 2010 Feb;254(2):636.</citation>
    <PMID>19561254</PMID>
  </results_reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 15, 2016</study_first_submitted>
  <study_first_submitted_qc>May 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 18, 2016</study_first_posted>
  <last_update_submitted>September 9, 2017</last_update_submitted>
  <last_update_submitted_qc>September 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hamilton Health Sciences Corporation</investigator_affiliation>
    <investigator_full_name>Hema Choudur</investigator_full_name>
    <investigator_title>Associate Professor, Department of Radiology</investigator_title>
  </responsible_party>
  <keyword>calcific tendonitis</keyword>
  <keyword>rotator cuff calcific tendonitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tendinopathy</mesh_term>
    <mesh_term>Rotator Cuff Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

